Meeting Archive:
The Promise of PrEP for Transgender and Cisgender Women of Color


Meeting Description:

Women of color are one of the fastest growing populations infected with HIV, including transwomen of color who have one of the highest rates of HIV infection. Pre-exposure prophylaxis (PrEP) is the newest and most promising biomedical HIV prevention intervention for transgender and cisgender women of color who are at risk for HIV infection through sex and injecting drug use. Many women may not be aware that PrEP exists and is an option available to them, and concerns about potential negative effects of PrEP on gender- affirming hormone therapy may also represent a barrier to PrEP acceptability for transwomen. Overall, there is a need for providers to increase awareness of PrEP among transgender and cisgender women of color and address clinical barriers to uptake and use of PrEP. Thus, it is critical to support clinical providers in identifying HIV-negative women at high risk, engaging them in PrEP, and ensuring that PrEP users remain adherent and linked to clinical care.

This training will introduce clinical and social providers, and health care professionals to the current research on PrEP as a prevention intervention. Participants will gain an understanding of barriers and facilitators for transgender and cisgender women of color. 

For more information, please click here for the brochure.
Details
Date: Wed, May 31, 2017
Time: 10:30 AM EDT
Duration: 1 hour 30 minutes
Host(s): Rachel Joiner-Escola
 Presenter Information
Ayana Elliot, DNP, APRN, FNP-C
Speaker Photo

Ayana Elliott received her undergraduate nursing degrees from the University of the District of Columbia, followed by a Master’s of Science degree - Family Nurse Practitioner at the University Of Maryland School Of Nursing in Baltimore, MD. She received her Doctor of Nursing Practice degree from Chatham University in Pittsburgh, PA. 
 
Dr. Elliott has clinical expertise in family medicine, medical oncology, HIV and transgender health.
 
She is currently the Director of Clinical Operations at the City of Hope Comprehensive Cancer Center in South Pasadena, CA. 
 
Dr. Elliott's major projects include consulting and co-investigator roles in behavioral health studies and clinical research protocols identifying structural barriers to testing, prevention and treatment of HIV along with methodologies to enhance the quality of care to HIV+ transgender women of color. As an entrepreneur, she serves as the principal and lead health consultant for The Elliott Group, LLC.